Lataa...
PCSK9 Monoclonal Antibodies: An Overview
PCSK9 monoclonal antibodies are novel lipid-lowering therapy that have been extensively studied in patients with hypercholesterolemia either as monotherapy or as an add-on to other LLTs. PCSK9 monoclonal antibodies have significantly reduced the low-density lipoprotein cholesterol (LDL-C) plasma lev...
Tallennettuna:
| Julkaisussa: | Heart Views |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wolters Kluwer - Medknow
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7507904/ https://ncbi.nlm.nih.gov/pubmed/33014302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_20_20 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|